Dr Khalid A. Fakhro
Director of Precision Medicine, Sidra Medicine
|Date||16 January 2020 (Thursday)|
Experimental Medicine Building (EMB) Learning Studio
59 Nanyang Drive
About the Seminar
Achieving “personalized medicine” will require high quality genome interpretation, tailored to individuals in the context of their native populations. Over the past 5 years in Qatar there have been significant advances in this domain, driven by initial explorations of population genetic structure to identification of disease-causing genes and loci underlying both rare (Mendelian) and complex disorders. Through sequencing thousands of Qataris to date, we have demonstrated a significantly under-appreciated diversity of modern day Arabs, as well as identified founder alleles for a numerous diseases relevant to the regional population.
This talk will cover the ambitious trajectory that the genomic enterprise has taken in Qatar in recent years – e.g. establishing the Qatar Genome Programme, and building capacity and a knowledge based economy – and identify areas of opportunity for collaborators and industry partners looking to shape the evolving field of precision medicine in the Arab world.